Diagnosis and management of benign prostatic hyperplasia.

作者: Jonathan L Edwards

DOI:

关键词:

摘要: Benign prostatic hyperplasia is a common condition affecting older men. Typical presenting symptoms include urinary hesitancy, weak stream, nocturia, incontinence, and recurrent tract infections. Acute retention, which requires urgent bladder catheterization, relatively uncommon. Irreversible renal damage rare. The initial evaluation should assess the frequency severity of impact on patient's quality life. American Urological Association Symptom Index validated instrument for objective assessment symptom severity. also digital rectal examination urinalysis. Men with hematuria be evaluated cancer. A palpable nodule or induration prostate referral to rule out For men mild symptoms, watchful waiting annual reassessment appropriate. Over past decade, numerous medical surgical interventions have been shown effective in relieving benign hyperplasia. Alpha blockers improve quickly. Although 5-alpha reductase inhibitors slower onset action, they may decrease size alter disease course. Limited evidence shows that herbal agents saw palmetto extract, rye grass pollen pygeum relieve symptoms. Transurethral resection often provides permanent relief. Newer laser-based techniques comparable effectiveness transurethral up two years after surgery lower perioperative morbidity. Various outpatient are associated reduced morbidity, but relief less durable.

参考文章(34)
Stephen Bent, Christopher Kane, Katsuto Shinohara, John Neuhaus, Esther S Hudes, Harley Goldberg, Andrew L Avins, None, Saw Palmetto for Benign Prostatic Hyperplasia The New England Journal of Medicine. ,vol. 354, pp. 557- 566 ,(2006) , 10.1056/NEJMOA053085
Timothy Wilt, Roderick MacDonald, Areef Ishani, Indy Rutks, Gerold Stark, Cernilton for benign prostatic hyperplasia Cochrane Database of Systematic Reviews. ,(2011) , 10.1002/14651858.CD001042
Liam C. Wilson, Peter J. Gilling, Andrew Williams, Katie M. Kennett, Chris M. Frampton, Andre M. Westenberg, Mark R. Fraundorfer, A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. European Urology. ,vol. 50, pp. 569- 573 ,(2006) , 10.1016/J.EURURO.2006.04.002
John M. Eisenberg, Agency for Health Care Policy and Research. Medical Care. ,vol. 37, pp. 217- 219 ,(1998) , 10.1097/00005650-199903000-00001
Herbert Lepor, William O. Williford, Michael J. Barry, Michael K. Brawer, Christopher M. Dixon, Glenn Gormley, Clair Haakenson, Madeline Machi, Perinchery Narayan, Robert J. Padley, The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia The New England Journal of Medicine. ,vol. 335, pp. 533- 539 ,(1996) , 10.1056/NEJM199608223350801
Mark S Soloway, F. Civantos, J. E. Pinto, Histopathological effects of androgen deprivation in prostatic cancer. Seminars in Urologic Oncology. ,vol. 14, pp. 22- 31 ,(1996)
B. L. McClennan, J. G. Blaivas, R. C. Bruskewitz, Claus Roehrborn, V. Hasselblad, D. M. Eddy, J. H. Wasson, P. C. Albertsen, M. J. Barry, J. E. Oesterling, R. G. Roberts, J. L. Lange, S. E. Denton, A. J. Bueschen, J. D. McConnell, N. J. Reilly, S. A. Sacks, W. K. Mebust, H. L. Holtgrewe, Benign prostatic hyperplasia: Diagnosis and treatment American Family Physician. ,vol. 49, pp. 1157- 1165 ,(1994)
John D. McConnell, Reginald Bruskewitz, Patrick Walsh, Gerald Andriole, Michael Lieber, H. Logan Holtgrewe, Peter Albertsen, Claus G. Roehrborn, J. Curtis Nickel, Daniel Z. Wang, Alice M. Taylor, Joanne Waldstreicher, The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia New England Journal of Medicine. ,vol. 338, pp. 557- 563 ,(1998) , 10.1056/NEJM199802263380901